MORANDI, Anita
 Distribuzione geografica
Continente #
NA - Nord America 2.265
EU - Europa 2.067
AS - Asia 1.061
AF - Africa 27
SA - Sud America 8
OC - Oceania 5
Totale 5.433
Nazione #
US - Stati Uniti d'America 2.259
GB - Regno Unito 714
CN - Cina 563
SG - Singapore 352
IT - Italia 255
RU - Federazione Russa 243
SE - Svezia 218
IE - Irlanda 177
FR - Francia 150
DE - Germania 114
FI - Finlandia 101
UA - Ucraina 36
VN - Vietnam 33
TG - Togo 22
HK - Hong Kong 21
KR - Corea 20
TR - Turchia 16
BE - Belgio 15
ID - Indonesia 11
JP - Giappone 10
NL - Olanda 10
IN - India 9
GR - Grecia 8
TH - Thailandia 8
AU - Australia 5
ES - Italia 5
BR - Brasile 4
CA - Canada 4
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
AT - Austria 3
LV - Lettonia 3
AR - Argentina 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
NG - Nigeria 2
PL - Polonia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BY - Bielorussia 1
CH - Svizzera 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
Totale 5.433
Città #
Southend 656
Chandler 396
Singapore 299
Jacksonville 278
Ann Arbor 196
Woodbridge 193
Dublin 177
Ashburn 139
Beijing 128
New York 94
Houston 73
Wilmington 72
Lawrence 61
Princeton 61
Verona 61
Boardman 54
Bologna 47
Helsinki 40
Jinan 38
Nanjing 34
Dearborn 33
Redmond 26
Shenyang 25
Dong Ket 24
Hebei 24
Changsha 23
Falls Church 22
Lomé 22
Los Angeles 20
Sindelfingen 20
Santa Clara 19
Redwood City 16
Tianjin 16
Zhengzhou 16
Brussels 15
Seoul 15
Hong Kong 14
Norwalk 14
Seattle 14
Hangzhou 12
Ningbo 12
Washington 12
Haikou 11
Taiyuan 11
Dallas 10
Nanchang 10
Tokyo 10
Fuzhou 9
Milan 9
Munich 9
Jakarta 8
Jiaxing 8
Kent 8
Romola 8
Amsterdam 7
Taizhou 7
Crespellano 6
Sant'Ambrogio di Valpolicella 6
Fairfield 5
Guangzhou 5
Moscow 5
Asan 4
Auburn Hills 4
Bari 4
Cagliari 4
Florence 4
Frankfurt am Main 4
Lappeenranta 4
London 4
Rome 4
Shenzhen 4
Almaty 3
Chengdu 3
Dongguan 3
Edinburgh 3
Hefei 3
Mainz 3
North Bergen 3
Paris 3
Perugia 3
Riva 3
Athens 2
Baku 2
Bangkok 2
Bonndorf 2
Cambridge 2
Canberra 2
Carlsbad 2
Chicago 2
Chions 2
Cipolletti 2
Clearwater 2
Cremona 2
Delhi 2
Düsseldorf 2
Esslingen am Neckar 2
Falkenberg 2
Kailua 2
Kochi 2
Lagos 2
Totale 3.771
Nome #
Anthropometric indices are not satisfactory predictors of metabolic comorbidities in obese children and adolescents. 152
Glucose-independent association of adiposity and diet composition with cardiovascular risk in children and adolescents with type 1 diabetes 150
Predictors of metabolic risk in childhood obesity 145
A Rare Case of Granuloma Annulare in a 5-Year-Old Child With Type 1 Diabetes and Autoimmune Thyroiditis 125
Difficult Management of Glucose Homeostasis in a 21-Month-Old Child With Type 1 Diabetes and Unknown Glutaric Aciduria Type I: A Case Report 119
Diabetic ketoacidosis at diagnosis: role of family history and class II HLA genotypes 118
Metabolic and hormonal consequences of two different meals after a moderate intensity exercise bout in obese prepubertal children 112
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels. 110
Epicardial fat, abdominal adiposity and insulin resistance in obese pre-pubertal and early pubertal children. 108
Estimation of newborn risk for child oradolescent obesity: lessons fromlongitudinal birth cohorts 102
Health consequences of obesity in children and adolescents 102
Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. 100
Bias in food intake reporting in children and adolescents with type 1 diabetes: the role of body size, age and gender 100
Epidemiology of type 1 diabetes mellitus in the pediatric population in Veneto Region, Italy 99
High-fat meal, systemic inflammation and glucose homeostasis in obese children and adolescents 96
Prevalenza di obesità, sovrappeso e ipertensione in un campione di bambini del Comune di Verona 95
Childhood obesity classification systems and cardiometabolic risk factors: a comparison of the Italian, World Health Organization and International Obesity Task Force references 93
Estimation of Newborn Risk for Child or Adolescent Obesity: Lessons from Longitudinal Birth Cohorts 91
13C/12C breath test ratio after the ingestion of a meal naturally enriched with (13C)carbohydrates is a surrogate marker of insulin resistance and insulin sensitivity in children and adolescents with Type 1 Diabetes 90
Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study. 89
Nutritional education and carbohydrate counting in children with type 1 diabetes treated with continuous subcutaneous insulin infusion: the effects on dietary habits, body composition and glycometabolic control. 86
Fasting plasma glucose (FPG) and the risk of impaired glucose tolerance in obese children and adolescents. 85
Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. 84
Protein Intake as a Risk Factor of Overweight/Obesity in 8- to 12-Year-Old Children 84
Diet, physical, and biochemical characteristics of children and adolescents with type 1 diabetes: relationship between dietary fat and glucose control. 83
Biochemical parameters and anthropometry predict NAFLD in obese children 81
Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. 79
A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries. 79
Effect of Maternal Obesity on Foetal Growth and Metabolic Health of the Offspring 79
Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths 78
Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity 77
Influence of genetic variants in FADS2 and ELOVL2 genes on BMI and PUFAs homeostasis in children and adolescents with obesity 76
Diagnosis, treatment and prevention of pediatric obesity: consensus position statement of the Italian Society for Pediatric Endocrinology and Diabetology and the Italian Society of Pediatrics 75
A girl with incomplete Prader-Willi syndrome and negative MS-PCR, found to have mosaic maternal UPD-15 at SNP array 74
Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents 72
Circulating mitochondrial DNA is decreased in children and adolescents with obesity and/or insulin resistance 72
Urogenital complications of obesity 71
Minor diplotypes of FMO3 might protect children and adolescents from obesity and insulin resistance 71
“IGT-like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentration during the oral glucose tolerance test 70
The Q121 Variant of ENPP1 May Protect From Childhood Overweight/obesity in the Italian Population. 68
Associations Between Type 2 Diabetes-Related Genetic Scores and Metabolic Traits, in Obese and Normal-Weight Youths 68
Nonalcoholic Fatty Liver Disease and Estimated Insulin Resistance in Obese Youth: A Mendelian Randomization Analysis 68
Diet macronutrient composition reported before treatment predicts BMI change in obese children: the role of lipids. 65
Nutrition habits of children and adolescents with type 1 diabetes changed in a 10 years span 65
Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children 65
Fluid intake and hydration status in obese vs normal weight children 64
Il trattamento con bifosfonati in età evolutiva. Aspetti e indicazioni nelle patologie secondarie dello scheletro-parte prima. 63
A new index to simplify the screening of hypertension in overweight or obese youth 62
Prevention of obesity in toddlers (PROBIT): a randomised clinical trial of responsive feeding promotion from birth to 24 months 60
Il trattamento con bifosfonati in età evolutiva. Aspetti generali e indicazioni nelle patologie secondarie dello scheletro- parte seconda 59
Interaction between Streptococcus pneumoniae and Staphylococcus aureus in paediatric patients suffering from an underlying chronic disease. 54
Central Systolic Blood Pressure Is Associated With Early Vascular Damage in Children and Adolescents With Type 1 Diabetes 54
Feasibility and effectiveness of a distance-adapted physical activity intervention in adolescents with obesity during the COVID-19 pandemic 53
Long chain fatty acids metabolism and cardiovascular risk factors in youth with type 1 diabetes 53
Policaptil Gel Retard Intake Reduces Postprandial Triglycerides, Ghrelin and Appetite in Obese Children: A Clinical Trial 51
Body composition and insulin resistance in children 50
The American Academy of Pediatrics hypertension guidelines identify obese youth at high cardiovascular risk among individuals non-hypertensive by the European Society of Hypertension guidelines 49
Early marker of ocular neurodegeneration in children and adolescents with type 1 diabetes: the contributing role of polymorphisms in mir146a and mir128a genes 48
A new simple formula built on the American Academy of Pediatrics criteria for the screening of hypertension in overweight/obese children 47
Oxidative stress in youth with type 1 diabetes: Not only a matter of gender, age, and glycemic control 43
Genetic Variation in Antioxidant Response Modulates the Level of Oxidative Stress in Youth with Type 1 Diabetes and Poor Glycemic Control 42
Elevated blood pressure, cardiometabolic risk and target organ damage in youth with overweight and obesity 37
Cardiovascular risk factors in children and adolescents with type 1 diabetes mellitus: the role of insulin resistance and associated genetic variants 35
Preclinical signs of liver and cardiac damage in youth with metabolically healthy obese phenotype 32
FADS cluster variants are associated with insulin sensitivity in children and adolescents with overweight and obesity 30
Risk factors for pre-clinical atherosclerosis in adolescents with type 1 diabetes 30
A new formula to improve the screening of impaired glucose tolerance in youths with overweight or obesity 29
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 28
Serum zonulin as an index of glucose dysregulation in children and adolescents with overweight and obesity 26
A new proposal for a second insulin bolus to optimize postprandial glucose profile in adolescents with type 1 diabetes 25
Impact of the 2017 Blood Pressure Guidelines by the American Academy of Pediatrics in overweight/obese youth 25
Sex differences in cardiovascular risk factors of children and adolescents with type 1 diabetes mellitus: A role for diet? 23
Correction to: A new proposal for a second insulin bolus to optimize postprandial glucose profile in adolescents with type 1 diabetes 21
The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetology, Italian Society of Pediatrics and Italian Society of Pediatric Surgery 21
Lipid and saturated fatty acids intake and cardiovascular risk factors of obese children and adolescents 21
IGF1 and PPARG polymorphisms are associated with reduced estimated glomerular filtration rate in a cohort of children and adolescents with type 1 diabetes 20
Aiming for the Best Glycemic Control Beyond Time in Range: Time in Tight Range as a new CGM Metric in Children and Adolescents with Type 1 Diabetes using Different Treatment Modalities 19
The risk of metabolic derangements is higher in children and adolescents with overweight or obesity born small for gestational age 19
Uric acid, impaired fasting glucose and impaired glucose tolerance in youth with overweight and obesity 19
Screening for hypertension in young people with obesity: Feasibility in the real life 16
Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD? 15
Metabolic Issues in Adolescence 15
Glucose sensor with predictive alarm for hypoglycaemia: Improved glycaemic control in adolescents with type 1 diabetes 14
Urogenital Complications: Renal Disease, Urolithiasis and Lower Urinary Tract Symptoms 14
One-Hour Post-Load Plasma Glucose and Altered Glucometabolic Profile in Youths with Overweight or Obesity 14
The rehabilitation of children and adolescents with severe or medically complicated obesity: an ISPED expert opinion document 14
Glycaemic control metrics and metabolic dysfunction-associated steatotic liver disease in children and adolescents with type 1 diabetes 12
Association of HDL-Cholesterol, hypertension and left ventricular hypertrophy in youths with overweight or obesity 12
Systemic anti-oxidant capacity is inversely correlated with systolic blood pressure and pulse pressure in children with obesity 12
Which Is the Most Appropriate Cut-Off of HbA1c for Prediabetes Screening in Caucasian Youths with Overweight or Obesity? 11
High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity 11
Phenotypes of prediabetes and metabolic risk in Caucasian youths with overweight or obesity 9
Correction: Prevention of obesity in toddlers (PROBIT): a randomised clinical trial of responsive feeding promotion from birth to 24 months 9
Sex-Related Differences in Cardiovascular Risk in Adolescents with Overweight or Obesity 9
Optimising healthcare transition of adolescents and young adults to adult care: a perspective statement of the Italian Society of Obesity 9
Uric acid versus metabolic syndrome as markers of fatty liver disease in young people with overweight/obesity 9
Variant reclassification over time decreases the level of diagnostic uncertainty in monogenic obesity: Experience from two centres 8
Time in tight range in automated insulin delivery system users: Real-world data from children and adolescents with type 1 diabetes 4
Totale 5.600
Categoria #
all - tutte 21.771
article - articoli 21.027
book - libri 0
conference - conferenze 351
curatela - curatele 0
other - altro 277
patent - brevetti 0
selected - selezionate 0
volume - volumi 116
Totale 43.542


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020430 0 0 0 0 63 80 71 52 18 41 38 67
2020/2021562 42 91 21 89 85 58 11 30 14 13 67 41
2021/2022543 39 204 4 41 30 23 9 32 20 7 32 102
2022/20231.161 69 128 95 189 94 279 19 102 116 13 39 18
2023/2024839 25 61 72 87 89 152 42 45 10 47 116 93
2024/2025839 114 107 117 416 85 0 0 0 0 0 0 0
Totale 5.600